Homeopathy’s Triumph in ITP Treatment Offers New Hope for Blood Disorders

Indore (Madhya Pradesh) [India], July 16: A groundbreaking advancement in the treatment of blood disorders has emerged from Advanced Homoeo Health Center and Homeopathic Medical Research Pvt. Ltd., located at Geeta Bhawan, Indore. Under the leadership of Dr. A.K. Dwivedi, a senior homeopathic physician, member of the Scientific Advisory Board (CCRH), Ministry of AYUSH, Government of India, and Executive Council Member at Devi Ahilya Vishwavidyalaya, Indore, a revolutionary approach in homeopathy is offering renewed hope for patients battling rare and life-threatening conditions like Immune Thrombocytopenia (ITP), Aplastic Anemia, and Myelodysplastic Syndrome (MDS).

A compelling success story has captured medical attention: 7-year-old Ayushmann Singh from Azamgarh, Uttar Pradesh, was diagnosed with severe ITP, with platelet levels critically low at just 8,000. After undergoing 12 months of continuous and evidence-based homeopathic treatment using advanced 50 millesimal potency, Ayushmann’s platelet count dramatically increased to 2.3 lakhs, allowing him to return to a normal life—attending school, playing with friends, and enjoying a healthy childhood once again.

“This is more than a medical case—it is a message of hope,” said Dr. Dwivedi. “In immune thrombocytopenia, the body’s own immune system destroys its platelets. Our specialized approach in homeopathy offers not only symptom relief but addresses the patient’s complete physical, emotional, and mental wellbeing.”

Conventional treatments for ITP, such as long-term steroid use, immunoglobulins, or bone marrow transplants, often come with limited efficacy and severe side effects. In contrast, Dr. Dwivedi’s patient-centered and scientifically grounded homeopathic protocols present a low-risk and sustainable alternative, especially in chronic and difficult-to-treat conditions.

Widely acclaimed as “Hope for the Bloodless”, Dr. Dwivedi is known for his pioneering work in treating aplastic anemia and promoting anemia awareness through homeopathy. His efforts are inspiring growing interest in integrating homeopathy into mainstream healthcare conversations, especially for conditions with limited conventional solutions.

The case of young Ayushmann has become a beacon for families seeking effective and gentle treatment paths, underscoring the potential of homeopathy not as an alternative, but as a serious and scientifically validated medical choice.

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More